A promise of nose to brain delivery of bevacizumab intranasal sol–gel formulation substantiated in rat C6 glioma model
- Type
- Retraction
- Notice date
- 4/21/2025 0:00
- Journal
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1007/s00210-025-04177-w
- Original paper DOI
- 10.1007/s00210-024-03536-3